x

Posted 04 March, 2021

cbdMD, Inc. appointed new CEO

CEO Change detected for ticker NYSE:YCBD in a 8-K filed on 04 March, 2021.


  As previously reported, effective October 1, 2020 Mr. T. Ronan Kennedy joined cbdMD, Inc. as its Chief Executive Officer. On March 3, 2021 our Board of Directors appointed Mr. Kennedy to also serve as our Chief Operating Officer.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of cbdMD, Inc.
Health Care/Life Sciences • Pharmaceuticals
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.
Market Cap
$2.12M
View Company Details
cbdMD, Inc. by TradingView
Relevant filing section
Item 5.02 

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.



 
 As previously reported, effective October 1, 2020 Mr. T. Ronan Kennedy joined cbdMD, Inc. as its Chief Executive Officer. On March 3, 2021 our Board of Directors appointed Mr. Kennedy to also serve as our Chief Operating Officer. Effective March 3, 2021 we entered into Amendment No. 1 to the Executive Employment Agreement ("Amendment No. 1") with Mr. Kennedy to reflect this additional role with our company. A copy of Amendment No. 1 is filed as Exhibit 10.1 to this report and incorporated herein by such reference.